This post was originally published on this site
Bristol-Myers Squibb announced earnings per share of $1.99 on revenue of $11.22. Analysts polled by Investing.com anticipated EPS of $1.82 on revenue of $11.15B.
Bristol-Myers Squibb shares are up 16% from the beginning of the year, still down 9.70% from its 52 week high of $80.59 set on June 27.
Bristol-Myers Squibb’s report follows an earnings beat by UnitedHealth on October 14, who reported EPS of $5.79 on revenue of $80.9B, compared to forecasts EPS of $5.43 on revenue of $80.52B.
J&J had beat expectations on October 18 with third quarter EPS of $2.55 on revenue of $23.79B, compared to forecast for EPS of $2.52 on revenue of $23.46B.
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com’s earnings calendar
